Livzon Pharmaceutical Group Inc Class H LVZPF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $3.11
- Day Range
- $3.20–3.20
- 52-Week Range
- $3.11–3.20
- Bid/Ask
- $3.01 / $4.01
- Market Cap
- $2.99 Bil
- Volume/Avg
- 108 / 108
Key Statistics
- Price/Earnings (Normalized)
- 10.85
- Price/Sales
- 1.73
- Dividend Yield (Trailing)
- 6.99%
- Dividend Yield (Forward)
- 0.90%
- Total Yield
- 6.99%
Company Profile
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment in PRC which is pharmaceutical manufacturing.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 8,933
- Website
- https://www.livzon.com.cn
Comparables
Valuation
|
Metric
|
LVZPF
|
000518
|
002864
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.85 | — | 24.24 |
Price/Book Value | 1.44 | 5.16 | 2.03 |
Price/Sales | 1.73 | 10.51 | 3.13 |
Price/Cash Flow | 5.49 | 617.92 | 18.22 |
Price/Earnings
LVZPF
000518
002864
Financial Strength
|
Metric
|
LVZPF
|
000518
|
002864
|
|---|---|---|---|
Quick Ratio | 1.79 | 0.79 | 3.04 |
Current Ratio | 2.06 | 4.40 | 3.20 |
Interest Coverage | 22.16 | −68.78 | 13.86 |
Quick Ratio
LVZPF
000518
002864
Profitability
|
Metric
|
LVZPF
|
000518
|
002864
|
|---|---|---|---|
Return on Assets (Normalized) | 7.52% | −6.38% | 5.56% |
Return on Equity (Normalized) | 13.59% | −8.66% | 9.38% |
Return on Invested Capital (Normalized) | 9.12% | −7.36% | 7.39% |
Return on Assets
LVZPF
000518
002864
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dbsvsfkn | Ssbfp | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Fdvdflkj | Jgsdxy | $70.9 Bil | |
HLN
| Haleon PLC ADR | Gjjcqkgm | Ytywj | $37.8 Bil | |
VTRS
| Viatris Inc | Hdzfdbt | Gglp | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wktgvtmd | Plgdv | $12.7 Bil | |
CTLT
| Catalent Inc | Qfnzqtsn | Rkmrtm | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Fmwbsxmdk | Cny | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Xclwbdq | Jmkhj | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hdktqwn | Vdhhc | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Sfdsnhrhjb | Fhzwk | $3.1 Bil |